Medical device and MedTech insights, news, tips and more

ArthroMeda gets $2M for hip replacement sensors

March 30, 2016


ArthroMedaIn order for arthroplasty surgery to restore proper joint function, surgeons must carefully align orthopedic implants. A Massachusetts startup is developing a simple sensor system that’s meant to improve the precision and efficacy of these arthroplasty surgeries.

ArthroMeda just raised $1.9 million, according to a regulatory filing, from four investors. This is its third fundraise – having brought in $1.6 million in 2014 and$695,000 in 2013.

Arthromeda uses micro-sensors to wirelessly connect to a software system that’ll help surgeons navigate the implantation process onscreen. Its digital templating software, called ArthroPlan, is meant to be a cost-effective tool that’s meant to be compatible with standard work stations, PCs and laptops.

The sensors are meant for hip replacements and other forms of orthopedic implantation surgery. In particular, it’s focusing on the total hip arthroplasty market – a sector which is projected to expand dramatically. There were 350,000 hip replacements in 2007; that’s expected to double by 2030, ArthroMed said. It’s also developing this technology for knee replacements.

Its process was rationalized in a 2013 press release by cofounder Mehran Aghazadeh:

THA was performed in 1960 for the first time. Although there have been numerous improvements in different aspects of this operation, from exposure and techniques to design and technology, most recent studies have shown that even highly experienced physicians still have difficulty positioning implants in proper angles. Using anatomical landmarks for this purpose is not sufficient, as they vary from patient to patient. There is a real need for a cost effective product and method for more accurate positioning of the implants in THA. We want to help surgeons be absolutely confident that they got the implant positioning right real-time.

Source: ArthroMeda gets $2M for hip replacement sensors – MedCity NewsMedCity News


More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.